目的:化疗药物对急性髓性白血病细胞体外毒性进行相关性研究。
Objective:To study the correlation between cytotoxicity of daunorubicine (DNR) and harringtonine (H) to leukemic cells in vitro from 39 patients with acute myeloblastic leukemia (AML).
目的:研究昆布多糖硫酸酯(LAMS)对急性髓性白血病HL - 6 0细胞株的调控作用。
Objective:To study the effects of LAMS on modulation of HL-60 cell strain.
结论:DCIK能诱导机体产生特异性的免疫反应,对急性髓细胞性白血病的治疗有较好的临床疗效。
Conclusion: DCIK can induce specific immunoreaction in the immune system and has satisfactory clinical anticancer efficacy in treatment of AML.
应用推荐